Related Experiment Video
Updated: Apr 7, 2026

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
INPP4B Is a Tumor Suppressor in the Context of PTEN Deficiency
Thanh-Trang T Vo1, David A Fruman2
1Department of Molecular Biology & Biochemistry, University of California, Irvine, California.
Abstract:
Enzymes (PI3K and PTEN) controlling cellular levels of 3-phosphorylated phosphoinositides are known as important drivers or suppressors of tumorigenesis in various cancers. In this issue of Cancer Discovery, Kofuji and colleagues and Chew and colleagues identify the lipid phosphatase INPP4B as a context-specific tumor suppressor that controls phosphoinositide levels and AKT2 activation in PTEN-deficient cells.
Insights
The lipid phosphatase INPP4B acts as a tumor suppressor in certain cancers. It regulates phosphoinositide levels and AKT2 activation, particularly in cells lacking PTEN, impacting tumorigenesis.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Phosphoinositide metabolism is crucial in cell signaling and tumorigenesis.
- Enzymes like phosphatidylinositol 3-kinase (PI3K) and phosphatase and tensin homolog (PTEN) regulate these pathways.
- Dysregulation of these enzymes contributes to various cancers.
Purpose of the Study:
- To investigate the role of the lipid phosphatase INPP4B in cancer.
- To determine how INPP4B influences phosphoinositide levels and signaling pathways.
- To identify INPP4B as a context-specific tumor suppressor.
Main Methods:
- Utilized molecular biology techniques to study INPP4B function.
- Analyzed phosphoinositide levels in cells with varying PTEN and INPP4B expression.
- Assessed the impact of INPP4B on AKT2 activation and downstream signaling.
Main Results:
- Identified INPP4B as a tumor suppressor in specific cellular contexts.
- Demonstrated that INPP4B controls phosphoinositide homeostasis.
- Showed that INPP4B negatively regulates AKT2 activation in PTEN-deficient cells.
Conclusions:
- INPP4B acts as a context-specific tumor suppressor.
- INPP4B's tumor-suppressive function is linked to its regulation of phosphoinositide levels.
- Targeting INPP4B may offer therapeutic strategies for PTEN-deficient cancers.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

